PCPep CollMD, MSVideoHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2018Long acting HIV drugs for prevention: what are the data? | Pep Coll, MDView Video
APAnton PozniakMD, FRCPVideoHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2018Long acting HIV drugs for treatment: what are the data? | Anton Pozniak, MD, FRCPView Video
SKSaye KhooMD, PhDVideoHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2018Improving drug delivery: what are the new technologies? | Saye Khoo, MD, PhDView Video
VideoHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2018How would the epidemic evolve in the future | David van de Vijver, PHARMD, PHDView Video
OSOana SăndulescuMD, PhDVideoHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2018The HIV epidemic in CEE countries | Oana Săndulescu, MD, PhDView Video
JRJürgen RockstrohMDVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on HIV & Hepatitis Co-infection 2017What challenges remain in viral hepatitis | Jürgen Rockstroh, MDView Video
NCNikoloz ChkhartishviliMD, MS, PhDVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on HIV & Hepatitis Co-infection 2017HCV elimination program in Georgia: Successes and challenges | Nikoloz Chkhartishvili, MD, MS, PhDView Video
VideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on HIV & Hepatitis Co-infection 2017Antifibrotics and fatty liver drugs in the pipeline | Sanjay Bhagani, MDView Video
VideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on HIV & Hepatitis Co-infection 2017NASH and NAFLD in HIV: same or different? | Mariana Machado, MDView Video
MPMarion PetersMDVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on HIV & Hepatitis Co-infection 2017Non liver and survival benefits of SVR in HCV | Marion Peters, MDView Video
VideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on HIV & Hepatitis Co-infection 2017The use of HIV+ or HCV+ organs in transplantation | Stefano Fagiuoli, MDView Video
DDDouglas DieterichMDVideoHIVViral Hepatitis and Liver DiseaseInternational Workshop on HIV & Hepatitis Co-infection 2017Are there any special populations in treatment of HCV left? | Douglas Dieterich, MDView Video
